Published in Curr Cancer Drug Targets on November 01, 2010
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
Multiple functional domains in the adenovirus E1A gene. Cell (1987) 4.22
TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell (1990) 3.55
Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes. Mol Cell Biol (1986) 3.52
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev (1995) 2.93
Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol (1993) 2.92
Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci U S A (2000) 2.59
Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev (1991) 2.40
Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products. Mol Cell Biol (1987) 2.38
Lytic and transforming functions of individual products of the adenovirus E1A gene. J Virol (1986) 2.14
Grant agencies must be seen to be fair. Nature (1999) 2.03
Proteasome inhibitors: antitumor effects and beyond. Leukemia (2006) 1.87
Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products. Mol Cell Biol (1991) 1.85
Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol (2005) 1.77
Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions. Cancer (1998) 1.76
p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene (1993) 1.76
Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest (2001) 1.71
CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res (1997) 1.70
Gene array analysis of osteoblast differentiation. Cell Growth Differ (2001) 1.64
Purification of human B cell growth factor. J Immunol (1985) 1.61
The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity. Mol Cell Biol (2000) 1.54
Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification. Mol Cell Biol (1991) 1.52
Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem (1998) 1.51
p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. Mol Cell Biol (1998) 1.47
Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes. J Virol (1997) 1.45
The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome. Am J Hum Genet (1999) 1.41
E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products. Mol Cell Biol (1991) 1.41
The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev (1990) 1.40
Heterotopic ossification after primary cemented and noncemented total hip arthroplasty in patients with osteoarthritis and rheumatoid arthritis. Can J Surg (1994) 1.40
Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains. Mol Cell Biol (1992) 1.37
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res (1997) 1.31
DNA-binding properties of the E1A-associated 300-kilodalton protein. Mol Cell Biol (1992) 1.31
Gambling as a form of dependence. Br J Addict Alcohol Other Drugs (1970) 1.29
Comparison of five methods for the assay of serum gentamicin. Antimicrob Agents Chemother (1981) 1.25
DNA damage induced by auramine O in liver, kidney, and bone marrow of rats and mice, and in a human cell line (alkaline elution assay and SCE induction). J Toxicol Environ Health (1982) 1.24
Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals. J Am Acad Dermatol (1986) 1.22
Soluble factor activation of human B lymphocytes. Nature (1981) 1.22
Geographical variations of place of death among Italian communities suggest an inappropriate hospital use in the terminal phase of cancer disease. Public Health (2000) 1.19
E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity. J Virol (1995) 1.17
Synthesis of p34, the mammalian homolog of the yeast cdc2+/CDC28 protein kinase, is stimulated during adenovirus-induced proliferation of primary baby rat kidney cells. Oncogene (1988) 1.12
Meningococcal vaccines--present and future. Trans R Soc Trop Med Hyg (1991) 1.11
Assessing research productivity in an oncology research institute: the role of the documentation center. Bull Med Libr Assoc (1997) 1.08
Inactivation of neutrophil-derived hypochlorous acid by nimesulide: a potential mechanism for the tissue protection during inflammation. Int J Tissue React (1990) 1.07
Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer (1983) 1.06
Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease. NIPH Ann (1991) 1.05
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. Acta Haematol (1993) 1.05
Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer. Cancer Res (1985) 1.04
Studies on DNA binding of caffeine and derivatives: evidence of intercalation by DNA-unwinding experiments. Biochim Biophys Acta (1989) 1.01
Pathophysiological role of neutrophils in acute myocardial infarction. Thromb Haemost (2013) 1.01
GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses. Br J Pharmacol (2011) 1.00
Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction. Oncogene (2006) 1.00
The role of specific DNA base damages in the X-ray-induced inactivation of bacteriophage PM2. Mutat Res (1985) 0.99
DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status. Br J Cancer (1997) 0.99
DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. Cancer Res (1981) 0.98
Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc Natl Acad Sci U S A (1996) 0.98
Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells. Invasion Metastasis (1991) 0.97
Inhibition of neutrophil cytolysin production by target cells. Blood (1986) 0.96
32P-postlabeling detection of DNA adducts in mice treated with the herbicide Roundup. Environ Mol Mutagen (1998) 0.96
Relative survival in elderly cancer patients in Europe. EUROCARE Working Group. Eur J Cancer (1998) 0.96
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer (2013) 0.95
The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300. J Virol (1993) 0.95
Immunodetection of human T-cell lymphotropic virus type I core protein in biological samples by using a monoclonal antibody immunoassay. J Clin Microbiol (1990) 0.95
Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor. J Cell Biol (1987) 0.95
Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans. Kidney Int (2006) 0.94
Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res (1998) 0.93
Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage. Clin Cancer Res (1999) 0.92
Defective antibody-dependent tumour cell lysis by neutrophils from cancer patients. Clin Exp Immunol (1989) 0.92
Varieties of pathological gambling. Br J Psychiatry (1970) 0.92
Transcriptional regulation of the mouse ferritin H gene. Involvement of p300/CBP adaptor proteins in FER-1 enhancer activity. J Biol Chem (1999) 0.91
The relationship between urban airborne pollution and short-term mortality: quantitative and qualitative aspects. Eur J Epidemiol (2000) 0.91
Relationship between antibody-dependent tumour cell lysis and primary granule exocytosis by human neutrophils. Clin Exp Immunol (1987) 0.91
Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study. Br J Cancer (2006) 0.91
The condensation of chromatin in apoptotic thymocytes shows a specific structural change. J Biol Chem (1997) 0.91
Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11. Haematologica (2000) 0.91
Characterization and quantitation of the active polynucleotide fraction (PDRN) from human placenta, a tissue repair stimulating agent. J Pharm Biomed Anal (1996) 0.90
Reliability and validity of the grading of heterotopic ossification. J Arthroplasty (1994) 0.90
Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53. Int J Cancer (1997) 0.89
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. Curr Cancer Drug Targets (2012) 0.89
An inter-regional comparison: fatal crashes in the southeastern and non-southeastern United States: preliminary findings. Accid Anal Prev (1999) 0.89
Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes. Gene Ther (2003) 0.89
Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases. Kidney Int (2006) 0.88
Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer. J Cell Biochem (2000) 0.88
MDR1 expression is associated with adverse survival in melanoma of the uveal tract. Hum Pathol (1998) 0.88
Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. Inflammation (1991) 0.88
Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res (1999) 0.88
Thermodynamics of condensation of nuclear chromatin. A differential scanning calorimetry study of the salt-dependent structural transitions. Biochemistry (1991) 0.88
Neutrophil-induced depletion of adenosine triphosphate in target cells: evidence for a hypochlorous acid-mediated process. J Lab Clin Med (1988) 0.87
Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity. Mol Biol Cell (1992) 0.87
The efficacy of tone-reducing features in orthotics on the gait of children with spastic diplegic cerebral palsy. J Pediatr Orthop (2000) 0.87
Relief of pruritus by cholestyramine in chronic liver disease. Isr J Med Sci (1965) 0.87
Augmentation of neutrophil-mediated erythrocyte lysis by cells derived in vitro from human monocytes. Blood (1987) 0.86
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres. Clin Microbiol Infect (2005) 0.86
Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics (2009) 0.85
Antibody-dependent tumour cytolysis by human neutrophils: effect of synthetic serine esterase inhibitors and substrates. Immunology (1987) 0.85
Induction of preneoplastic nodules: quantitative predictivity of carcinogenicity. Anticancer Res (1984) 0.85
Socioeconomic status and survival of gastric cancer patients. Eur J Cancer (1998) 0.85